Found 32 results
Author Title Type [ Year(Asc)]
Filters: Author is Carter, S  [Clear All Filters]
2012
C. A. Keever-Taylor, Devine, S. M., Soiffer, R. J., Mendizabal, A., Carter, S., Pasquini, M. C., Hari, P. N., Stein, A., Lazarus, H. M., Linker, C., Goldstein, S. C., Stadtmauer, E. A., and O'Reilly, R. J., Characteristics of CliniMACS® System CD34-Enriched T Cell-Depleted Grafts in a Multicenter Trial for Acute Myeloid Leukemia-Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Protocol 0303, Biol Blood Marrow Transplant, vol. 18, pp. 690-697, 2012.
M. Pasquini, Devine, S., Mendizabal, A., Baden, L. R., Wingard, J., Lazarus, H. M., Appelbaum, F. R., Keever-Taylor, C. A., Horowitz, M. M., Carter, S., O'Reilly, R. J., and Soiffer, R., Comparative Outcomes of Donor Graft CD34+ Selection and Immune Suppressive Therapy as Graft-Versus-Host Disease Prophylaxis for Patients with Acute Myeloid Leukemia in Complete Remission Undergoing HLA-Matched Sibling Allogeneic Hematopoietic Cell Transpl, J Clin Oncol, vol. 30, pp. 3194-3201, 2012.
K. M. Page, Zhang, L., Mendizabal, A., Wease, S., Carter, S., Shoulars, K., Gentry, T., Balber, A. E., and Kurtzberg, J., The Cord Blood Apgar: A Novel Scoring System to Optimize Selection of Banked Cord Blood Grafts for Transplantation (CME)., Transfusion, vol. 52, pp. 272-283, 2012.
C. Anasetti, Logan, B., Lee, S., Waller, E., Weisdorf, D., Wingard, J., Cutler, C., Westervelt, P., Woolfrey, A., Couban, S., Ehringer, G., Johnston, L., Maziarz, R., Pulsipher, M. A., Porter, D., Mineishi, S., McCarty, J., Khan, S., Anderlini, P., Bensinger, W., Leitman, S., Rowley, S., Bredeson, C., Carter, S., Horowitz, M., and Confer, D., Peripheral-Blood Stem Cells Versus Bone Marrow from Unrelated Donors, N Engl J Med, vol. 367, no. 16, pp. 1487-1496, 2012.
S. M. Devine, Owza, K., Blum, W., DeAngelo, D., Stone, R. M., Wingard, J., Champlin, R., Chen, Y., Vij, R., Slack, J., Brown, R., Soiffer, R., Larson, R., Shea, T., Hars, V., Bennett, E., Spangle, S., Giralt, S., Carter, S., Horowitz, M., Linker, C., and Alyea, E. P., A Phase II Study of Allogeneic Transplantation for Older Patients with AML in First Complete Remission Using a Reduced Intensity Conditioning Regimen: Results from CALGB 100103/BMT CTN 0502, in 54th Annual ASH Meeting, Atlanta, GA, 2012.
C. Cutler, Logan, B., Nakamura, R., Johnston, L., Choi, S., Porter, D., Hogan, W., Pasquini, M., MacMillan, M., Wingard, J., Waller, E., Grupp, S., McCarthy, P., Wu, J., Hu, Z., Carter, S., Horowitz, M. M., and Antin, J. H., Tacrolimus/Sirolimus vs. Tacrolimus/Methotrexate for GVHD Prophylaxis After HLA-Matched, Related Donor Hematopoietic Stem Cell Transplantation: Results of BMT CTN Trial 0402, in 54th Annual ASH Meeting, Atlanta, GA, 2012.
N. R. Kamani, Walters, M. C., Carter, S., Aquino, V., Brochstein, J. A., Chaudhury, S., Eapen, M., Freed, B. M., Grimley, M., Levine, J. E., Logan, B., Moore, T., Panepinto, J., Parikh, S., Pulsipher, M. A., Sande, J., Schultz, K. R., Spellman, S., and Shenoy, S., Unrelated Donor Cord Blood Transplantation for Children with Severe Sickle Cell Disease: Results of One Cohort from the Phase II Study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN), Biol Blood Marrow Transplant, vol. 18, pp. 1265-1272, 2012.
2010
C. Keever-Taylor, Devine, S., Soiffer, R., Carter, S., Pasquini, M., Hari, P., Stein, A., Lazarus, H., Linker, C., Goldstein, S., and O’Reilly, R., Characteristics of CD34-Enriched Products Processed at Multiple Centers Using the CliniMACS System - BMT CTN 0303 (Abstract)., in 16th Annual ISCT (International Society for Cellular Therapy) Meeting, Philadelphia, 2010.
C. Gurgol, Foley, A., Belt, P., Denzen, E., Duffy, S., Gallagher, C., Grodman, C., Horowitz, M., Confer, D., and Carter, S., Developing Materials for Transplant Centers to Share BMT CTN Clinical Trial Results with their Patients: A Pilot Study (Poster)., in NCI ASCO Cancer Trials Accrual Symposium, Bethesda, MD, 2010.
A. Foley, Horowitz, M., Confer, D., and Carter, S., Development of an Accrual Assessment Tool for BMT CTN Transplant Trials: A Proactive Approach, in NCI ASCO Cancer Trials Accrual Symposium Poster Session, Bethesda, MD, 2010.
M. Pasquini, Foley, A., Carter, S., Confer, D., Horowitz, M., Gurgol, C., Giralt, S., Schilsky, R., and McCarthy, P., Maximizing Accrual to Transplant Trials in Multiple Myeloma (MM): Lessons from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN), Eastern Cooperative Oncology Group (ECOG) and Cancer and Leukemia Group B (CALGB) Collaboration (Poster)., in NCI ASCO Cancer Trials Accrual Symposium, Bethesda, MD, 2010.
J. Wingard, Carter, S., Walsh, T., Kurtzberg, J., Small, T., Baden, L., Gersten, I., Mendizabal, A., Leather, H., Confer, D., Maziarz, R., Stadtmauer, E., Bolanos-Meade, J., Brown, J., DiPersio, J., Boeckh, M., and Marr, K., Randomized Double-blind Trial of Fluconazole vs Voriconazole for Prevention of Invasive Fungal Infection after Allo Hematopoietic Cell Transplantation, Blood, vol. 116, pp. 5111-5118, 2010.